IMA Wealth Inc. raised its holdings in shares of Evolent Health Inc (NYSE:EVH) by 11.7% during the third quarter, HoldingsChannel.com reports. The fund owned 142,642 shares of the technology company’s stock after buying an additional 14,967 shares during the period. Evolent Health accounts for approximately 1.6% of IMA Wealth Inc.’s portfolio, making the stock its 16th largest position. IMA Wealth Inc.’s holdings in Evolent Health were worth $4,051,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also bought and sold shares of the company. NumerixS Investment Technologies Inc bought a new stake in shares of Evolent Health in the second quarter worth about $105,000. LPL Financial LLC bought a new stake in shares of Evolent Health in the first quarter worth about $184,000. Xact Kapitalforvaltning AB bought a new stake in shares of Evolent Health in the first quarter worth about $190,000. Paloma Partners Management Co bought a new stake in shares of Evolent Health in the second quarter worth about $209,000. Finally, Brown Advisory Inc. bought a new stake in shares of Evolent Health in the second quarter worth about $210,000.

Several brokerages have recently issued reports on EVH. Leerink Swann set a $35.00 target price on Evolent Health and gave the stock a “buy” rating in a report on Friday, October 5th. Citigroup lifted their target price on Evolent Health from $25.00 to $32.00 and gave the stock a “buy” rating in a report on Thursday, October 4th. ValuEngine raised Evolent Health from a “buy” rating to a “strong-buy” rating in a report on Friday, September 14th. Canaccord Genuity lifted their target price on Evolent Health from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Thursday, September 13th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $32.00 target price (up from $28.00) on shares of Evolent Health in a report on Thursday, September 13th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Evolent Health currently has an average rating of “Buy” and an average price target of $29.69.

In related news, CEO Frank J. Williams sold 9,653 shares of Evolent Health stock in a transaction dated Wednesday, August 1st. The stock was sold at an average price of $19.97, for a total value of $192,770.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Jonathan Weinberg sold 15,000 shares of Evolent Health stock in a transaction dated Thursday, September 13th. The stock was sold at an average price of $27.12, for a total value of $406,800.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 214,260 shares of company stock valued at $5,433,522. 4.82% of the stock is currently owned by company insiders.

EVH traded down $0.23 on Thursday, hitting $25.00. The company had a trading volume of 20,139 shares, compared to its average volume of 866,163. The firm has a market cap of $2.23 billion, a P/E ratio of -35.80 and a beta of 1.19. Evolent Health Inc has a 12-month low of $10.30 and a 12-month high of $29.05. The company has a current ratio of 2.59, a quick ratio of 2.59 and a debt-to-equity ratio of 0.12.

Evolent Health (NYSE:EVH) last released its quarterly earnings results on Tuesday, August 7th. The technology company reported ($0.03) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.04) by $0.01. The company had revenue of $144.51 million during the quarter, compared to analyst estimates of $141.90 million. Evolent Health had a negative return on equity of 1.82% and a negative net margin of 9.84%. On average, research analysts forecast that Evolent Health Inc will post -0.36 earnings per share for the current fiscal year.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

See Also: How Do Tariffs Affect Trade Balances?

Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health Inc (NYSE:EVH).

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.